Liver Transplant Recipients: Clinical Trials

11 trials for Liver Transplant Recipients, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 1 recruiting, 1 unknown. 3 Phase 2, 2 Not applicable, 2 Phase 4, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Unknown 1
Not applicable2Completed 2
Phase 42Completed 2
Phase 31Unknown 1

Follow Liver Transplant Recipients: new trials by email Literature Review of Liver Transplant Recipients trials Research Report on Liver Transplant Recipients

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Liver Transplant Recipients and 30-Second Lie-to-Sit Test
30-second lie-to-sit test, Modified Borg Scale, waist circumference - Liver Transplant Recipients
RecruitingInonu University342025-11-082026-01-26
Effect of TCI Propofol on Liver Transplant (TCI) Propofol on Intra-operative Usage of Vasopressors in Liver Transplant Recipients.
Target control infusion propofol, Inhalational isoflurane - Liver Transplant Recipients
Phase 2 / Phase 3UnknownInstitute of Liver and Biliary Sciences, India602023-08-012024-05-17
COVID Protection After Transplant-Immunosuppression Reduction
Pfizer-BioNTech COVID-19 Vaccine 2023-2024, Moderna COVID-19 Vaccine 2023-2024, SOC IS Regimen - Kidney Transplant Recipients, Liver Transplant Recipients
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)482021-12-062026-04-23
Conversion From Sirolimus to Everolimus in the Maintenance Treatment of Liver Transplant Recipients
Liver Transplant Recipients
CompletedEge University662015-07-012016-12-21
Adult Liver Transplant Enhanced Care
Behavioral Telehealth - Liver Transplant Recipients
Not applicableCompletedIcahn School of Medicine at Mount Sinai82015-01-012016-12-09
Pharmacokinetic Studies of Tacrolimus in Transplant Patients
Prograf, Tacrolimus - Kidney Transplant Recipients, Liver Transplant Recipients
Phase 4CompletedUniversity of Cincinnati782013-06-012016-02-22
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients
Immunosuppression withdrawal - Liver Transplant Recipients, Liver Transplantation
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1612012-08-142019-10-07
Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients
Liver Transplant Recipients, Liver Transplantation
CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2022012-08-012026-09-25
L-arginine for Prevention of Kidney Damage in Liver Transplant Recipients
L-arginine, Placebo - Liver Transplant Recipients
Not applicableCompletedMayo Clinic242008-11-012012-09-03
The Effects of Angiotensin II Receptor Blockade on Kidney Function and Scarring After Liver Transplant
Cozaar - Liver Transplant Recipients
Phase 4CompletedMayo Clinic622004-12-012012-01-06
Blood Draw Study for Liver Transplant Patients
Liver Transplant Recipients
CompletedBaylor Research Institute2212002-10-152026-01-26

Narrower conditions

COVID-19 (1)  ·  Medication Adherence (1)

Broader conditions

Behavior (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Health Behavior (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  Patient Acceptance of Health Care (1)  ·  Patient Compliance (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Treatment Adherence and Compliance (1)

Interventions

Tacrolimus (2)  ·  2019-nCoV Vaccine mRNA-1273 (1)  ·  Arginine (1)  ·  BNT162 Vaccine (1)  ·  COVID-19 Vaccines (1)  ·  CVnCoV COVID-19 vaccine (1)  ·  Immunosuppression Therapy (1)  ·  Losartan (1)  ·  Mycophenolic Acid (1)  ·  Standard of Care (1)  ·  Waist Circumference (1)  ·  lepirudin (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (3)  ·  Mayo Clinic (2)  ·  Baylor Research Institute (1)  ·  Ege University (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Inonu University (1)  ·  Institute of Liver and Biliary Sciences, India (1)  ·  University of Cincinnati (1)

Countries

United States (8)  ·  Turkey (Türkiye) (2)  ·  Canada (1)  ·  India (1)

Top investigators

Christian P. Larsen, MD, DPhil (1)  ·  Dorry L. Segev, MD, PhD (1)  ·  Eyal Shemesh, MD (1)  ·  Goran Klintmalm, MD (1)  ·  Ilker Turan, M.D. (1)  ·  J Bucuvalas, M.D. (1)  ·  Josh Levitsky, MD, MS (1)  ·  K.V. Narayanan Menon, M.D. (1)  ·  Michael Abecassis, MD, MBA (1)  ·  Peter S. Heeger, MD (1)  ·  Rita R Alloway, PharmD, FCCP (1)  ·  S Feng, M.D., Ph.D. (1)  ·  W. Ray Kim (1)

Results publications

PMID 29135993, PMID 32786149, PMID 33280227, PMID 35819312

NIH funding

R21AT004174 (1), U01AI100807 (1), U01AI138897 (1)